Patent assignee · CA · COMPANY

NEURODYN, INC.

3Patents
3Active
3Granted
43Portfolio score

Filing activity: Jun 29, 2006 → Mar 30, 2012 · 2 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8148336B2 Sterol glucoside toxins Emerging Cross-Sectional Technologies 2 Active
US8497123B2 Sterol glucoside toxins Emerging Cross-Sectional Technologies 1 Active
US9573972B2 Nurotoxic sterol glycosides Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.